AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2017
Mar 2, 2017
32870_dirs_2017-03-01_892d5823-7220-4501-bf64-46903b899536.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2017-02-27
Reporting Person: Abdun-Nabi Daniel (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-27 | Common Stock | M | 3662 | $30.63 | Acquired | 192824 | Direct |
| 2017-02-27 | Common Stock | F | 1735 | $30.63 | Disposed | 191089 | Direct |
| 2017-02-27 | Common Stock | F | 984 | $30.63 | Disposed | 190105 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-27 | Stock Option - (Right to Buy) | $14.51 | M | 3662 | Disposed | 2017-03-08 | Common stock (3662) | Direct |
Footnotes
F1: Consists of options granted under the Amended and Restated Emergent BioSolutions Inc 2006 Stock Incentive Plan, as amended.
F2: The option vested in three equal installments in March 2011, March 2012 and March 2013.
F3: Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock options.
F4: Consists of shares withheld from the option exercise and delivered to the issuer to satisfy the reporting persons tax withholding obligations.